Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Improvement of Blood Pressure Control by Adherence Check in Patients With Apparent Treatment-Resistant Hypertension: A Case Series.

Hosohata K, Inada A, Oyama S, Doi T, Niinomi I, Wakabayashi T, Uchida M, Iwanaga K, Matsuoka H.

Clin Med Insights Case Rep. 2020 Feb 17;13:1179547620904884. doi: 10.1177/1179547620904884. eCollection 2020.

2.

Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database.

Niinomi I, Hosohata K, Mori Y, Yamaguchi Y, Wakabayashi T, Uchida M, Iwanaga K.

J Pharm Health Care Sci. 2019 Oct 7;5:21. doi: 10.1186/s40780-019-0149-z. eCollection 2019.

3.

Involvement of Vanin-1 in Ameliorating Effect of Oxidative Renal Tubular Injury in Dahl-Salt Sensitive Rats.

Hosohata K, Jin D, Takai S, Iwanaga K.

Int J Mol Sci. 2019 Sep 11;20(18). pii: E4481. doi: 10.3390/ijms20184481.

4.

Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database.

Niinomi I, Hosohata K, Oyama S, Inada A, Wakabayashi T, Iwanaga K.

Int J Toxicol. 2019 Nov/Dec;38(6):487-492. doi: 10.1177/1091581819870717. Epub 2019 Aug 30.

PMID:
31470743
5.

Augmentation of cadmium-induced oxidative cytotoxicity by pioglitazone in renal tubular epithelial cells.

Hosohata K, Mise N, Kayama F, Iwanaga K.

Toxicol Ind Health. 2019 Aug;35(8):530-536. doi: 10.1177/0748233719869548.

PMID:
31462196
6.

Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database.

Uchida M, Kondo Y, Suzuki S, Hosohata K.

Ann Pharmacother. 2019 Dec;53(12):1200-1206. doi: 10.1177/1060028019865870. Epub 2019 Jul 26.

PMID:
31347378
7.

Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: Subgroup analysis based on a Japanese spontaneous database.

Inada A, Oyama S, Niinomi I, Wakabayashi T, Iwanaga K, Hosohata K.

J Clin Pharm Ther. 2019 Oct;44(5):775-779. doi: 10.1111/jcpt.13001. Epub 2019 Jun 23.

PMID:
31231846
8.

Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database.

Hosohata K, Oyama S, Niinomi I, Wakabayashi T, Inada A, Iwanaga K.

Clin Drug Investig. 2019 Jul;39(7):665-670. doi: 10.1007/s40261-019-00788-3.

PMID:
31054085
9.

Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy.

Uchida M, Nakamura T, Shima T, Mori Y, Yoshimoto G, Kato K, Shimokawa M, Hosohata K, Miyamoto T, Akashi K.

Pharmazie. 2019 Apr 1;74(4):250-254. doi: 10.1691/ph.2019.8889.

PMID:
30940311
10.

A Novel Biomarker for Acute Kidney Injury, Vanin-1, for Obstructive Nephropathy: A Prospective Cohort Pilot Study.

Washino S, Hosohata K, Oshima M, Okochi T, Konishi T, Nakamura Y, Saito K, Miyagawa T.

Int J Mol Sci. 2019 Feb 19;20(4). pii: E899. doi: 10.3390/ijms20040899.

11.

Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database.

Hosohata K, Inada A, Oyama S, Niinomi I, Wakabayashi T, Iwanaga K.

Clin Drug Investig. 2019 Apr;39(4):363-368. doi: 10.1007/s40261-019-00754-z.

PMID:
30689189
12.

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database.

Inada A, Hosohata K, Oyama S, Niinomi I, Mori Y, Yamaguchi Y, Uchida M, Iwanaga K.

Ther Clin Risk Manag. 2018 Dec 24;15:59-64. doi: 10.2147/TCRM.S176620. eCollection 2019.

13.

Comparative Quantification of Chemotherapy-Induced Nausea and Emesis between the Common Terminology Criteria for Adverse Events and the Multinational Association of Supportive Care in Cancer Antiemesis Tool.

Uchida M, Nakamura T, Shima T, Yoshimoto G, Kato K, Hosohata K, Miyamoto T, Akashi K.

Biol Pharm Bull. 2018;41(11):1667-1671. doi: 10.1248/bpb.b18-00336.

14.

Vanin-1 in Renal Pelvic Urine Reflects Kidney Injury in a Rat Model of Hydronephrosis.

Hosohata K, Jin D, Takai S, Iwanaga K.

Int J Mol Sci. 2018 Oct 16;19(10). pii: E3186. doi: 10.3390/ijms19103186.

15.

Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database.

Oyama S, Hosohata K, Inada A, Niinomi I, Mori Y, Yamaguchi Y, Uchida M, Iwanaga K.

Ther Clin Risk Manag. 2018 Sep 5;14:1599-1604. doi: 10.2147/TCRM.S168696. eCollection 2018.

16.

Differential profiles of adverse events associated with mycophenolate mofetil between adult and pediatric renal transplant patients.

Hosohata K, Matsuoka E, Inada A, Oyama S, Niinomi I, Mori Y, Yamaguchi Y, Uchida M, Iwanaga K.

J Int Med Res. 2018 Nov;46(11):4617-4623. doi: 10.1177/0300060518786917. Epub 2018 Jul 30.

17.

Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.

Hosohata K, Inada A, Oyama S, Furushima D, Yamada H, Iwanaga K.

J Clin Pharm Ther. 2019 Feb;44(1):49-53. doi: 10.1111/jcpt.12748. Epub 2018 Jul 16.

PMID:
30014591
18.

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy.

Uchida M, Nakamura T, Makihara Y, Suetsugu K, Ikesue H, Mori Y, Kato K, Shiratsuchi M, Hosohata K, Miyamoto T, Akashi K.

Pharmazie. 2018 May 1;73(5):304-308. doi: 10.1691/ph.2018.7948.

PMID:
29724299
19.

Can Focal Segmental Glomerulosclerosis Be Differentiated From Minimal Change Nephrotic Syndrome Using Biomarkers?

Hosohata K.

Am J Med Sci. 2018 Apr;355(4):305-306. doi: 10.1016/j.amjms.2018.01.003. Epub 2018 Jan 31. No abstract available.

PMID:
29661342
20.

Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting.

Uchida M, Nakamura T, Hata K, Watanabe H, Mori Y, Kato K, Kamezaki K, Takenaka K, Shiratsuchi M, Hosohata K, Miyamoto T, Akashi K.

J Pharm Health Care Sci. 2018 Jan 9;4:1. doi: 10.1186/s40780-017-0097-4. eCollection 2018.

21.

Early urinary biomarkers of renal tubular damage by a high-salt intake independent of blood pressure in normotensive rats.

Washino S, Hosohata K, Jin D, Takai S, Miyagawa T.

Clin Exp Pharmacol Physiol. 2018 Mar;45(3):261-268. doi: 10.1111/1440-1681.12871. Epub 2017 Dec 20.

PMID:
29027259
22.

Biomarkers for Chronic Kidney Disease Associated with High Salt Intake.

Hosohata K.

Int J Mol Sci. 2017 Sep 30;18(10). pii: E2080. doi: 10.3390/ijms18102080. Review.

23.

Effect of a dosing-time on quetiapine-induced acute hyperglycemia in mice.

Kapse S, Ando H, Fujiwara Y, Suzuki C, Ushijima K, Kitamura H, Hosohata K, Kotani K, Shimba S, Fujimura A.

J Pharmacol Sci. 2017 Mar;133(3):139-145. doi: 10.1016/j.jphs.2017.02.008. Epub 2017 Feb 17.

24.

Role of Oxidative Stress in Drug-Induced Kidney Injury.

Hosohata K.

Int J Mol Sci. 2016 Nov 1;17(11). pii: E1826. Review.

25.

Early prediction of cisplatin-induced nephrotoxicity by urinary vanin-1 in patients with urothelial carcinoma.

Hosohata K, Washino S, Kubo T, Natsui S, Fujisaki A, Kurokawa S, Ando H, Fujimura A, Morita T.

Toxicology. 2016 Jun 1;359-360:71-5. doi: 10.1016/j.tox.2016.06.011. Epub 2016 Jun 16.

PMID:
27317936
26.

Influence of genetic polymorphisms of multidrug and toxin extrusion protein 1 on its mRNA expression in peripheral blood cells.

Ando H, Nakano K, Ushijima K, Kurokawa S, Washino S, Hosohata K, Morita T, Fujimura A.

J Pharmacol Sci. 2016 Jun;131(2):138-40. doi: 10.1016/j.jphs.2016.03.002. Epub 2016 Mar 11.

27.

Early urinary biomarkers for renal tubular damage in spontaneously hypertensive rats on a high salt intake.

Hosohata K, Yoshioka D, Tanaka A, Ando H, Fujimura A.

Hypertens Res. 2016 Jan;39(1):19-26. doi: 10.1038/hr.2015.103. Epub 2015 Sep 17.

PMID:
26376947
28.

Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury.

Nakano K, Ando H, Kurokawa S, Hosohata K, Ushijima K, Takada M, Tateishi M, Yonezawa A, Masuda S, Matsubara K, Inui K, Morita T, Fujimura A.

Cancer Chemother Pharmacol. 2015 Jun;75(6):1191-7. doi: 10.1007/s00280-015-2743-6. Epub 2015 Apr 11.

PMID:
25862351
29.

Urinary Kim-1 is a sensitive biomarker for the early stage of diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats.

Hosohata K, Ando H, Takeshita Y, Misu H, Takamura T, Kaneko S, Fujimura A.

Diab Vasc Dis Res. 2014 Jul;11(4):243-250. Epub 2014 May 12.

PMID:
24821754
30.

Temsirolimus induces surfactant lipid accumulation and lung inflammation in mice.

Washino S, Ando H, Ushijima K, Hosohata K, Kumazaki M, Mato N, Sugiyama Y, Kobayashi Y, Fujimura A, Morita T.

Am J Physiol Lung Cell Mol Physiol. 2014 Jun 15;306(12):L1117-28. doi: 10.1152/ajplung.00251.2013. Epub 2014 May 2.

31.

Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.

Hosohata K, Uesugi M, Hashi S, Hosokawa M, Inui K, Matsubara K, Ogawa K, Fujimoto Y, Kaido T, Uemoto S, Masuda S.

Drug Metab Pharmacokinet. 2014;29(1):83-9. Epub 2013 Aug 13.

32.

cGMP-dependent protein kinase Iβ interacts with p44/WDR77 to regulate androgen receptor-driven gene expression.

Zhou L, Hosohata K, Gao S, Gu Z, Wang Z.

PLoS One. 2013 Jun 3;8(6):e63119. doi: 10.1371/journal.pone.0063119. Print 2014.

33.

Dosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosis.

Ando H, Otoda T, Ookami H, Nagai Y, Inano A, Takamura T, Ushijima K, Hosohata K, Matsushita E, Saito T, Kaneko S, Fujimura A.

Clin Exp Pharmacol Physiol. 2013 Mar;40(3):227-32. doi: 10.1111/1440-1681.12055.

PMID:
23323567
34.

Early detection of renal injury using urinary vanin-1 in rats with experimental colitis.

Hosohata K, Ando H, Fujimura A.

J Appl Toxicol. 2014 Feb;34(2):184-90. doi: 10.1002/jat.2849. Epub 2013 Jan 11.

PMID:
23307618
35.

Relationship between the receptor occupancy profile and pleiotropic effects of angiotensin II receptor blockers.

Ando H, Ushijima K, Hosohata K, Saito T, Fujimura A.

Br J Clin Pharmacol. 2013 Feb;75(2):415-22. doi: 10.1111/j.1365-2125.2012.04358.x.

36.

Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.

Hosohata K, Ando H, Fujimura A.

J Pharmacol Exp Ther. 2012 Jun;341(3):656-62. doi: 10.1124/jpet.112.192807. Epub 2012 Mar 7.

PMID:
22399813
37.

Vanin-1: a potential biomarker for nephrotoxicant-induced renal injury.

Hosohata K, Ando H, Fujiwara Y, Fujimura A.

Toxicology. 2011 Nov 28;290(1):82-8. doi: 10.1016/j.tox.2011.08.019. Epub 2011 Sep 3.

PMID:
21907259
38.

Molecular basis of secretin docking to its intact receptor using multiple photolabile probes distributed throughout the pharmacophore.

Dong M, Lam PC, Pinon DI, Hosohata K, Orry A, Sexton PM, Abagyan R, Miller LJ.

J Biol Chem. 2011 Jul 8;286(27):23888-99. doi: 10.1074/jbc.M111.245969. Epub 2011 May 12.

39.

Protective effect of α-lipoic acid against arsenic trioxide-induced acute cardiac toxicity in rats.

Kumazaki M, Ando H, Sasaki A, Koshimizu TA, Ushijima K, Hosohata K, Oshima Y, Fujimura A.

J Pharmacol Sci. 2011;115(2):244-8. Epub 2011 Jan 26.

40.

Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine.

Maeda A, Ando H, Asai T, Ishiguro H, Umemoto N, Ohta M, Morishima M, Sumida A, Kobayashi T, Hosohata K, Ushijima K, Fujimura A.

Clin Pharmacol Ther. 2011 Feb;89(2):229-33. doi: 10.1038/clpt.2010.268. Epub 2010 Dec 22.

PMID:
21178986
41.

Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study.

Hosohata K, Masuda S, Yonezawa A, Sugimoto M, Takada Y, Kaido T, Ogura Y, Oike F, Uemoto S, Inui K.

Drug Metab Pharmacokinet. 2009;24(5):458-63.

42.

MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients.

Hosohata K, Masuda S, Yonezawa A, Katsura T, Oike F, Ogura Y, Takada Y, Egawa H, Uemoto S, Inui K.

Pharm Res. 2009 Jul;26(7):1590-5. doi: 10.1007/s11095-009-9867-5. Epub 2009 Mar 7.

PMID:
19267185
43.

Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients.

Hosohata K, Masuda S, Katsura T, Takada Y, Kaido T, Ogura Y, Oike F, Egawa H, Uemoto S, Inui K.

Drug Metab Dispos. 2009 Apr;37(4):821-6. doi: 10.1124/dmd.108.025833. Epub 2009 Jan 12.

PMID:
19139162
44.

Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5.

Hosohata K, Masuda S, Ogura Y, Oike F, Takada Y, Katsura T, Uemoto S, Inui K.

Drug Metab Pharmacokinet. 2008;23(2):134-8.

45.

Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.

Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, Katsura T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K.

Pharmacogenet Genomics. 2008 May;18(5):413-23. doi: 10.1097/FPC.0b013e3282f9ac01.

PMID:
18408564
46.

Reproducibility of nocturnal blood pressure assessed by self-measurement of blood pressure at home.

Hosohata K, Kikuya M, Ohkubo T, Metoki H, Asayama K, Inoue R, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y.

Hypertens Res. 2007 Aug;30(8):707-12.

PMID:
17917318
47.

Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.

Dong M, Lam PC, Gao F, Hosohata K, Pinon DI, Sexton PM, Abagyan R, Miller LJ.

Mol Pharmacol. 2007 Aug;72(2):280-90. Epub 2007 May 2.

PMID:
17475809
48.

Progress report on The Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study: status at February 2004.

Hosohata K, Saito S, Asayama K, Ohkubo T, Kikuya M, Metoki H, Obara T, Kato T, Hashimoto J, Totsune K, Miura Y, Imai Y; HOMED-BP Study Group.

Clin Exp Hypertens. 2007 Jan;29(1):69-81.

PMID:
17190733
49.

Differential spatial approximation between secretin and its receptor residues in active and inactive conformations demonstrated by photoaffinity labeling.

Dong M, Hosohata K, Pinon DI, Muthukumaraswamy N, Miller LJ.

Mol Endocrinol. 2006 Jul;20(7):1688-98. Epub 2006 Mar 2.

PMID:
16513792

Supplemental Content

Loading ...
Support Center